Health and Well-Being

In the wake of the COVID-19 pandemic, people have developed new expectations for indoor air quality. It is no longer just about ventilation and purification, but also about providing clean and safe air for a healthier environment. Traditional UVC technology (254 nm) has been widely used in HVAC systems and air purifiers to disinfect airborne pathogens. To ensure its effectiveness, sufficient contact time is required, hence it is often used in unoccupied spaces due to safety concerns.  This solution utilises human-safe 222 nm far-UVC technology which has been shown to be able to effectively inactivate airborne pathogens while maintaining safety since it does not penetrate the outer layer of human skin or eyes. This allows for continuous disinfection of air in occupied spaces. By integrating 222 nm far-UVC technology into HVAC system, including air purification, air monitoring and IoT management platforms, the company offers a complete solution for clean and safe air. With integrated capabilities in both R&D and manufacturing, the company can provide tailor-made solutions for different industry applications. They are seeking collaborations with real estate developers, chain restaurant operators and pathogenic air sampling technology experts to further develop and commercialise this solution.

Superoxide dismutase (SOD) is a key antioxidant enzyme that protects cells from oxidative stress by catalysing the conversion of superoxide radicals into less harmful molecules like oxygen and hydrogen peroxide. These radicals are produced during normal cellular metabolism but can cause significant damage to DNA, proteins, and lipids if not neutralised. SOD helps maintain cellular integrity by reducing this damage, supporting overall health and longevity. Given its role in protecting cell damage, SOD has been utilised in skincare products, cosmeceuticals, dietary supplements, medical and therapeutic products as well as functional foods. Current methods to produce SOD include natural extraction from plants, microbial fermentation and recombinant DNA technology. However, challenges such as low yield, variation in quality and concentration, high costs and regulatory issues still remain. The technology owner uses specific strains of microorganism and advanced biotechnology processes to produce SOD at high yields via fermentation in a sustainable and efficient manner. The enzyme is then extracted and concentrated during downstream processing. This technology could ensure a consistent and scalable supply of SOD for commercial use. The company is seeking collaborations with skincare brands and cosmetic manufacturers interested in co-developing or licensing the technology for mass-market production and distribution.

Graphene-based antibacterial composite materials are a class of materials that combine graphene's unique properties with antibacterial agents to create surfaces or textiles that can effectively kill or inhibit the growth of bacteria. With its inherent antibacterial properties, graphene’s large surface area and high conductivity makes it an ideal carrier for functional molecules that exhibit antibacterial properties naturally. The technology on offer is a proprietary process to prepare and application of a green and multifunctional graphene-based antibacterial composite material for textiles. These materials can be applied to various textile materials and products, possessing antibacterial, antiviral, and deodorizing properties. Featuring high efficiency (99%), broad-spectrum coverage, non-toxicity, functionalised textiles can be used in healthcare and consumer products for long-lasting and multifunctional antibacterial properties. It is non-leaching and more eco-friendly compared to traditional chemical antibacterial products. This technology can endow textile products with antibacterial, antiviral, and deodorizing properties, enhancing the added value of traditional textile materials for safe and non-toxic antibacterial performance. The technology owner is interested in joint R&D projects with companies looking to incorporate this graphene-based antibacterial composite and develop new eco-friendly and multifunctional antibacterial textile products.  

With the global population rapidly aging, the prevalence of dementia is becoming an increasing concern. As more elderly individuals suffer from cognitive decline, including memory loss and impaired daily functioning, the need for effective interventions is urgent. Dementia, a condition affecting many worldwide, not only diminishes the quality of life for patients but also places a heavy burden on caregivers and healthcare systems.  In response to these challenges, this solution offers a novel method to help dementia patients maintain cognitive function through engaging therapeutic activities. The solution is a cognitive stimulation system that leverages motion tracking and multi-sensory feedback to help users recall familiar actions from their daily lives. By recreating activities such as ironing or spreading jam, the device taps into procedural memory, allowing users to re-enact tasks they once performed regularly. This process stimulates recollection, helping to evoke personal memories and improve cognitive agility. The technology owner is interested to work with:  (1) companies to co-develop/ out-license the technology to help serve more patients and elderly; (2) healthcare facilities such as hospitals or nursing homes for validations and trials. 

Diabetic foot ulcers (DFUs) are a serious and common complication of diabetes, often leading to infections, amputations, and prolonged hospitalizations. Even with current standard of care, treatment of DFUs is still challenging, and may not always prevent severe outcomes. This therapy system integrates advanced wound management techniques, focusing on enhancing wound healing, off-loading pressure from vulnerable areas, and improving infection control. Traditional treatments lack comprehensive solutions for wound healing enhancement, pressure off-loading, and effective infection control. This therapy system combines these features into a single solution, offering accelerated healing while its integrated disinfection mechanism helps manage infections with ease. The therapy system is efficient and user-friendly, suitable for deployment in various healthcare settings. Ideal collaboration partners include medical device manufacturers, wound care specialists, and healthcare institutions focused on innovative treatment solutions.

Radar sensor technology, particularly at the millimeter-wave (mmWave) range, offers innovative ways to monitor human health by leveraging electromagnetic waves to gather vital signs non-invasively. This non-contact approach is highly effective for measuring heart rate and respiratory rate, enhancing comfort for users by eliminating the need for physical sensors. This mmWave radar detects small body movements, such as chest expansion and contractions due to breathing, as well as micro-movements from heartbeats. One of the key advantages of this technology is its ability to penetrate clothing and bedding, making it ideal for continuous monitoring in sleep studies, elderly care, and other medical applications. It also functions reliably regardless of lighting conditions or ambient noise, unlike optical or acoustic sensors. This radar technology allows for immediate data collection, enabling quick responses in emergencies and optimizing overall performance.

As a breakthrough in health technology, sleep health monitoring gained significant attention due to increasing awareness of sleep’s critical impact on physical and mental well-being. Demand for innovative solutions to address sleep disorders, particularly among aging populations and individuals with chronic illnesses, is rising. However, to fully unlock its potential, there are challenges to overcome, such as achieving clinical-grade accuracy, safeguarding data privacy, and ensuring seamless integration with existing healthcare systems. To address these challenges, the technology owner has developed a non-intrusive, highly convenient solution leveraging on advanced contactless vital signs sensor and an AIoT platform. This system tracks sleep patterns, detect breathing disorders and improve overall well-being by capturing heart rates, breathing patterns, and subtle body movements using high-precision fiber optic sensors. Through sophisticated signal processing, it collects and analyses multidimensional vital sign date such as ballistocardiogram (BCG), electrocardiogram (ECG) and photoplethysmography (PPG), using big data. AI algorithms further enhance the solution by providing comprehensive sleep quality assessments and personalized sleep recommendations. This contactless monitoring solution offered real-time, high-precision monitoring of vital signs without direct contact with the human body, ensuring medical-grade accuracy across a wide range of body weights. By eliminating the need for wearables or sensors, it enhances user comfort while providing critical insights into sleep quality - a key factor in mental, physical, and emotional health. The technology owner is seeking collaboration with industrial partners in healthcare facilities, eldercare centers, hospitals, sleep clinics, daycare centers, and smart homes to explore various application opportunities.

Insomnia, particularly when caused by stress or anxiety, poses a significant challenge for many individuals. Traditional treatments, including sleeping pills, can be effective but often come with potential side effects and long-term dependency concerns. Addressing this issue, an innovative sleep patch has been developed to offer a non-invasive, drug-free solution for improving sleep hygiene. This sleep patch is designed to tackle common sleep problems such as insomnia and irregular sleep patterns, particularly those triggered by stress and anxiety. Unlike conventional medications, the patch leverages natural products to promote relaxation and support continuous sleep without the adverse effects associated with long-term drug use. Clinical research, including stress experiments and polysomnography studies, has demonstrated the patch’s ability to induce sleep for over 12 hours by alleviating stress. This makes it an ideal choice for individuals seeking a safe, effective alternative to conventional sleep aids. The technology owner is looking for collaboration with local research institutions and universities to validate the effectiveness and safety of the product through comprehensive research and clinical trials.

In healthcare, accurately assessing pain is critical, yet it remains a significant challenge, particularly for patients unable to effectively communicate their discomfort. This includes individuals with cognitive impairments, critical care patients, and pre-verbal children. Traditional pain assessment methods rely heavily on verbal communication or subjective observer-based pain assessment, which can lead to missed or poorly managed pain, resulting in either under-treatment or over-analgesia treatment. To address this issue, this advanced AI-based solution automates the process of estimating pain intensity by analyzing facial expressions captured in video data. The technology is a deep learning system consisting of facial landmarks (specific points on a person's face, such as the corners of the eyes, nose, mouth, and other prominent facial features) extraction, 3D normalization and Spatial-Temporal Attention Long Short-Term Memory (STA-LSTM) model. These facial landmarks provide critical information about facial expressions, allowing the system to accurately assess pain levels. By integrating this technology into clinical settings, healthcare providers can significantly enhance patient care, reduce the burden on staff, and improve overall pain management practices. This solution not only ensures timely and appropriate intervention but also protects patient privacy by using non-identifiable facial landmarks, making it a powerful tool for modern healthcare environments.